We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
-$2.84M
Cap. Flow
-$11.5M
Cap. Flow %
-5.82%
Top 10 Hldgs %
37.09%
Holding
69
New
13
Increased
19
Reduced
13
Closed
21

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$4.41M
2
HUM icon
Humana
HUM
+$4.06M
3
LLY icon
Eli Lilly
LLY
+$4M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$3.86M
5
IART icon
Integra LifeSciences
IART
+$3.77M

Top Sells

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$6.04M
2
SYK icon
Stryker
SYK
+$5.99M
3
HCA icon
HCA Healthcare
HCA
+$5.46M
4
THC icon
Tenet Healthcare
THC
+$4.84M
5
ESRX
Express Scripts Holding Company
ESRX
+$4.11M

Sector Composition

Rank Sector Weight
1 Healthcare 91.46%
2 Financials 2.33%
3 Energy 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$8.03M 4.05%
100,000
+50,000
+100% +$4M
ZBH icon
2
Zimmer Biomet
ZBH
$18.2B
$7.8M 3.93%
61,800
– –
HUM icon
3
Humana
HUM
$43.7B
$7.67M 3.87%
43,382
+23,382
+117% +$4.06M
CELG
4
DELISTED
Celgene Corp
CELG
$7.58M 3.82%
72,500
+17,500
+32% +$1.89M
AMGN icon
5
Amgen
AMGN
$208B
$7.51M 3.78%
45,000
+10,000
+29% +$1.69M
MRK icon
6
Merck
MRK
$322B
$7.49M 3.78%
125,760
+31,440
+33% +$1.84M
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$7.35M 3.71%
60,000
+30,000
+100% +$3.86M
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$7.09M 3.57%
60,000
+20,000
+50% +$2.43M
AZN icon
9
AstraZeneca
AZN
$263B
$6.57M 3.31%
100,000
+45,000
+82% +$2.94M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.48M 3.27%
70,000
+30,000
+75% +$2.82M
BIIB icon
11
Biogen
BIIB
$30B
$6.26M 3.16%
20,000
– –
CNC icon
12
Centene
CNC
$30.7B
$6.03M 3.04%
180,000
-2,600
-1% -$90.3K
CI icon
13
Cigna
CI
$73.7B
$5.86M 2.96%
45,000
+25,000
+125% +$3.26M
INCY icon
14
Incyte
INCY
$24.2B
$5.66M 2.85%
60,000
+25,000
+71% +$2.11M
REGN icon
15
Regeneron Pharmaceuticals
REGN
$78.5B
$5.63M 2.84%
14,000
+4,000
+40% +$1.6M
MDT icon
16
Medtronic
MDT
$109B
$5.62M 2.83%
65,000
+5,000
+8% +$436K
GSK icon
17
GSK
GSK
$104B
$5.39M 2.72%
100,000
+20,000
+25% +$1.1M
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
$5.27M 2.66%
45,000
+20,000
+80% +$2.23M
UNH icon
19
UnitedHealth
UNH
$376B
$4.9M 2.47%
35,000
+20,000
+133% +$2.8M
TMO icon
20
Thermo Fisher Scientific
TMO
$213B
$4.77M 2.41%
30,000
– –
BSX icon
21
Boston Scientific
BSX
$69.5B
$4.76M 2.4%
200,000
-100,000
-33% -$2.39M
MOH icon
22
Molina Healthcare
MOH
$10.2B
$4.67M 2.35%
+80,000
New +$4.41M
AET
23
DELISTED
Aetna Inc
AET
$4.62M 2.33%
40,000
+10,000
+33% +$1.17M
VRTX icon
24
Vertex Pharmaceuticals
VRTX
$121B
$4.36M 2.2%
50,000
-15,000
-23% -$1.42M
BDX icon
25
Becton Dickinson
BDX
$45.6B
$4.04M 2.04%
23,063
+2,563
+13% +$438K
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
FF
Fairway Financial Casselberry, Florida $132M AUM 13.23% 1-Year Est. Return
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM

Sivik Global Healthcare's Q3 2016 Portfolio in Review

As of Q3 2016, Sivik Global Healthcare held 69 positions worth $198M, down 1.4% from $201M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare withdrew a net $11.5M in Q3 2016, closing 21 positions and reducing 13 holdings. Its most notable exit was Universal Health Services, an estimated $6.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 90% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Molina Healthcare worth $4.67M.

  • Sivik Global Healthcare's largest Q3 2016 buy was Molina Healthcare: 80,000 shares worth $4.67M.
  • Sivik Global Healthcare added most to Humana in Q3 2016, an estimated $4.06M increase.
  • Sivik Global Healthcare's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $2.39M.
  • Sivik Global Healthcare fully exited Universal Health Services in Q3 2016, selling an estimated $6.04M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $198M portfolio in Q3 2016.
  • Sivik Global Healthcare opened 13 new positions and closed 21 in Q3 2016.
  • Sivik Global Healthcare's portfolio value fell 1.4% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q3 2016, filed 14 Nov 2016.